Peter B Illei, MD
Disclosures: Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca|Stocks or stock options, excluding diversified mutual funds-Bristol-Myers Squib Aventis|Grant or research support-Bristol-Myers Squib Aventis|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squib Aventis (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Roche (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Johnson and Johnson (Relationship has ended)|Consulting Fee-Genentech, Inc. (Relationship has ended)|Speakers Bureau-Eli Lilly and Company (Relationship has ended)|Grant or research support-ERBE GmBH (Relationship has ended) - 07/18/2022
No Bio Available.